Tally Not Rising Due To Hybrid Immunity -Top Health Expert

14 December, 2022 | Pragati Singh

XE Covid-19 Health & Environment

Dr. Arora further said, "India isn't getting affected even after South Asian countries reporting several cases because of the hybrid immunization."

N K Arora, the chairman of the NTAGI COVID-19 Working Group, stated on Wednesday that despite South Asian nations reporting an increase in COVID-19 cases, India remained untouched by the disease because to hybrid vaccination.

Dr. Arora did issue a warning that India should not let its guard down. India had a one-day increase of 152 COVID-19 cases on Wednesday, although there were no fatalities for the third day in a row.

While talking to ANI, Dr. N K Arora, “India still needs to be vigilant.”

He said, “I would say, we need to maintain a complete vigil on the quality of genetic surveillance as part of INSACOG.”

“We have been discussing this for three years in India but during the last three months, the cases have gradually come down and it is less than around 500-600 cases every day. Although 2,00,000 tests are being done every day and deaths are between five to 10 every day and sometimes even no deaths are reported. Most of these deaths are in your region with comorbidity and an incidental finding of COVID infection,” he said.

Dr. Arora further said, “India isn’t getting affected even after South Asian countries reporting several cases because of the hybrid immunization.”

“There is an outbreak of an increase in the number of cases in several South Asian countries as well as China, Japan, and Australia. Fortunately, 97 percent of our adult population has got two doses. Most of us have got natural infections. So there is a hybrid immunization and we are not seeing any serious outcome,” he added.